COFCO Biotechnology Co

COFCO Biotechnology Co ROE

The Return on Equity (ROE) of COFCO Biotechnology Co (000930.SZ) as of Oct 20, 2026 is 0.36 %. In the previous year, Return on Equity (ROE) was 0.24 % — a change of 51.34% (higher).

ROE

0.36 %

YoY

51.34%

Last updated:

In 2025, COFCO Biotechnology Co's return on equity (ROE) was 0.36 %, a 51.34% increase from the 0.24 % ROE in the previous year.

The COFCO Biotechnology Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
5.24 CNY
Jan 1, 2019
6.03 CNY
Jan 1, 2020
5.71 CNY
Jan 1, 2021
9.91 CNY
Jan 1, 2022
8.75 CNY
Jan 1, 2023
-5.76 CNY
Jan 1, 2024
0.24 CNY
Jan 1, 2025
0.36 CNY
The COFCO Biotechnology Co ROE history
YEARROEYoY
0.36 %+51.34%
0.24 %-104.15%
-5.76 %-165.80%
8.75 %-11.73%
9.91 %+73.68%
5.71 %-5.40%
6.03 %+15.22%
5.24 %-89.84%
51.52 %+532.81%
8.14 %-108.24%
-98.78 %-8,199.44%
1.22 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

COFCO Biotechnology Co Stock analysis

What does COFCO Biotechnology Co do? COFCO Biotechnology Co Ltd, listed on the Shenzhen Stock Exchange under ticker 000930.SZ, operates as a chemical manufacturing company based in Bengbu, Anhui, China. The company went public on July 12, 1999, and currently employs 8,286 people. Its primary business involves the production and sale of various chemical products, including fuel ethanol, edible alcohol, starch, starch sugar, citric acid, and monosodium glutamate, along with their by-products. The firm also produces amino acid products, edible oil, and L-lactic acid, distributing these goods both domestically and internationally. COFCO Biotechnology's headquarters are located in Bengbu, a city in Anhui Province, and it maintains a website at www.cofcotech.com for further information. The company is part of the Materials sector, specifically within the Chemicals industry, focusing on industrial chemical production and distribution. It does not disclose specific details about its founding year beyond the IPO date, nor does it provide information on acquisitions, key personnel, or detailed financial figures beyond the employee count. The company's operations are centered around chemical manufacturing, with a focus on products used in both industrial and consumer applications. Its product portfolio includes a range of chemical compounds and derivatives, supporting various sectors such as food processing, pharmaceuticals, and biofuels. The firm's market presence spans China and international markets, though specific regional breakdowns or market share data are not provided in the available information. COFCO Biotechnology Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding COFCO Biotechnology Co's Return on Equity (ROE)

COFCO Biotechnology Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing COFCO Biotechnology Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

COFCO Biotechnology Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in COFCO Biotechnology Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about COFCO Biotechnology Co stock

Return on Equity (ROE) of COFCO Biotechnology Co is 0.36 % in 2025.

Return on Equity (ROE) of COFCO Biotechnology Co changed from 0.24 % to 0.36 %, representing a 51.34% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) COFCO Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s COFCO Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — COFCO Biotechnology Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — COFCO Biotechnology Co